Preeclampsia prevention by timed birth at term
Pre-eclampsia is a condition that can develop after 20 weeks of pregnancy. It causes high blood pressure and can affect organs like the kidneys and liver. Delivering the baby is the only way to cure it, but choosing the safest time for birth can be difficult. This study looks at whether checking for pre-eclampsia risk at 35 to 36 weeks can prevent mothers and babies from becoming unwell. Pregnant women who take part are placed into one of two groups by chance. One group receives standard NHS maternity care. The other group has extra screening, including blood tests and blood pressure checks. If tests show a higher risk, doctors will plan the birth between 37 and 41 weeks. Researchers hope this approach will lower the chances of dangerous complications without increasing the need for emergency caesarean sections.
At a glance
What is this study about?
Pre-eclampsia is a serious health condition that can happen during the second half of pregnancy. It is marked by high blood pressure and protein in the urine. While many cases are mild, it can sometimes lead to severe complications for both mother and baby if left untreated. At present, the only way to stop pre-eclampsia is to deliver the baby and the placenta.
Doctors already know that delivering babies around their due date helps women who already have pre-eclampsia. However, researchers want to find out if planning an early-term birth can stop the condition from developing in the first place. This trial is testing whether an extra screening check towards the end of pregnancy can identify who is most at risk.
Women taking part at 35 to 36 weeks of pregnancy are placed into one of two groups. One group gets standard NHS antenatal care. The other group receives specialized screening that combines blood pressure readings, medical history, and blood tests. If the screening shows a higher chance of developing pre-eclampsia, the team will recommend planning the birth at 37, 38, 39, 40, or 41 weeks, depending on the risk level.
The main goal is to protect mothers from severe illness and keep babies safe. Researchers hope to gather clear evidence to help the NHS decide whether this screening and planned birth approach should become normal care for all pregnant women in the future.
Key takeaways
- Pre-eclampsia is a serious blood pressure condition that happens in later pregnancy.
- This trial tests if checking risk at 35 to 36 weeks and planning birth can prevent pre-eclampsia.
- Participants are randomly chosen to receive either standard NHS care or an extra screening assessment.
- Women found to have a higher risk may be offered a planned birth between 37 and 41 weeks.
- Taking part is completely voluntary and you can leave the study at any time.
Who may be eligible?
This trial is open to pregnant women aged 16 and older who are carrying a single baby. To take part, you must be between 35 weeks and 36 weeks plus 6 days into your pregnancy, and your baby must be growing well.
You cannot take part if you are under 16, if you are expecting twins or triplets, or if you have already been diagnosed with pre-eclampsia during this pregnancy. Women whose babies have been diagnosed with a major physical abnormality, or who are already taking part in another clinical trial that could affect the results, are also unable to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 16 or over.
- I am pregnant with one baby (not twins or triplets).
- I am currently between 35 weeks and 36 weeks plus 6 days pregnant.
- I have not been diagnosed with pre-eclampsia in this pregnancy.
- My baby has no known major health or physical conditions.
- I am not currently taking part in another pregnancy trial that affects my care.
What does participation involve?
Taking part begins when you are 35 to 36 weeks pregnant. A computer will place you at random into either the standard care group or the intervention group. If you are in the standard care group, your pregnancy visits will continue exactly as normal. If you are in the intervention group, you will have extra screening tests: your blood pressure will be measured, and a small blood sample will be taken to check for specific proteins linked to pre-eclampsia.
There are no trial medicines to take. Instead, the main action is planning the timing of your baby's birth. If your test results show you are at higher risk, your care team will discuss planning your delivery between 37 and 41 weeks. This could be done by inducing labour or through a planned caesarean section, depending on your individual situation. Your participation lasts until you and your baby are discharged after birth.
Potential risks and benefits
Locations (2)
- King's College HospitalApproximateLondon, England
- Medway Maritime Hospital LaboratoryCity onlyGillingham, England
Common questions
What is pre-eclampsia?
Pre-eclampsia is a condition that causes high blood pressure and protein in the urine during pregnancy. It can cause headaches, vision problems, and swelling, and can be dangerous if not monitored closely.
Will I definitely have to give birth early if I take part?
No. If you are in the standard care group, your birth plan will not change because of the study. If you are in the screened group, early birth is only suggested if your test results show you have a higher risk of pre-eclampsia.
Does planned birth mean having an emergency caesarean?
No. Birth can be started using medication to induce labour, or by a planned caesarean if needed. Studies show that planned early birth does not increase the risk of an emergency caesarean.
Where is this trial taking place?
The trial is based in the UK at King's College Hospital in London and Medway Maritime Hospital in Kent.
What happens if I decide to withdraw from the study?
You can leave the trial at any point. Your doctors and midwives will respect your decision, and you will continue to receive full NHS maternity care as normal.
How to find out more
Angel Leung
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.